OPENNESS AND TRANSPARENCY IN COVID-19 FINANCING, VACCINE PROCUREMENT AND DEPLOYMENT: A COMPARATIVE ANALYSIS FROM SELECTED AFRICAN COUNTRIES (original) (raw)
Related papers
Transparency in Nigeria's public pharmaceutical sector: perceptions from policy makers
Globalization and Health, 2009
Background: Pharmaceuticals are an integral component of health care systems worldwide, thus, regulatory weaknesses in governance of the pharmaceutical system negatively impact health outcomes especially in developing countries . Nigeria is one of a number of countries whose pharmaceutical system has been impacted by corruption and has struggled to curtail the production and trafficking of substandard drugs. In 2001, the National Agency for Food and Drug Administration and Control (NAFDAC) underwent an organizational restructuring resulting in reforms to reduce counterfeit drugs and better regulate pharmaceuticals . Despite these changes, there is still room for improvement. This study assessed the perceived level of transparency and potential vulnerability to corruption that exists in four essential areas of Nigeria's pharmaceutical sector: registration, procurement, inspection (divided into inspection of ports and of establishments), and distribution.
Anti-Corruption Review in global health
İlköğretim Online, 2021
This article has attempted to identify key priority areas that urgently need global attention to advance the fight against corruption in the health sector. The problem has become even more obvious and relevant in the context of the coronavirus pandemic. Over two-thirds of countries are considered endemically corrupt according to Transparency International. Corruption can be seen in all societies. It is estimated that the world spends more than US$7 trillion on health services, and that at least 10-25% of global spending is lost directly through corruption, representing hundreds of billions of dollars lost each year.
Cureus
A robust health system demands investments in public health and healthcare as they aid in closing the health protection gap. They are primarily responsible for longer life expectancies, disease prevention, and protection. Loopholes in the public health system were formed due to a lack of transparency and have only worsened throughout COVID-19. Spending more on public health is associated with fewer deaths, fewer food-borne illnesses, better sanitation, food safety, clean air and water, increased immunizations to stave against infectious diseases, and a decline in low birth weight. A comprehensive literature and data search was conducted using web-based search engines like PubMed, National Center for Biotechnology Information (NCBI), Google Scholar, Science Direct, and the New England Journal of Medicine. The review study standpoints healthcare spending, out-of-pocket expenditures, and other monetary use in various low-tohigh-income countries, and the results are graphically represented. Countries with a strong public health system provide all the necessary aid to protect their citizens. They have cost-effective, readily available resources with fewer out-of-pocket expenditures (OOPs), government schemes, and health insurance to help their people. During our research, it was found how little the Indian government spends on healthcare as a percentage of gross domestic product (GDP) as compared to 'thought-to-be' poor countries like Bhutan.
Recalibrating the anti-corruption, transparency, and accountability formula to advance public health
Global Health Action, 2020
Policy-makers, implementing organizations, and funders of global health programs aim to improve health care services and health outcomes through specific projects or systemic change. To mitigate the risk of corruption and its harmful effects on those initiatives, health programs often use multiple anti-corruption mechanisms, including codes of conduct, documentation and reporting requirements, and trainings. Unfortunately, the introduction of anti-corruption mechanisms tends to occur without an explicit consideration of how each mechanism will affect health services and health outcomes. This may overlook potentially more effective approaches. In addition, it may result in the introduction of too many controls (thereby stymying service delivery) and a focus on financial or procurement-related issues (at the expense of service delivery objectives). We argue that anti-corruption efforts in health programs can be more effective if they prioritize addressing issues according to their likelihood and level of harm to key program objectives. Recalibrating the anti-corruption formula in this way will require: (i) extending responsibility and ownership over anti-corruption from subject experts to public health and health system specialists, and (ii) enabling those specialists to apply the Fraud Risk Assessment methodology to develop tailored anticorruption mechanisms. We fill a documented gap in guidance on how to develop anticorruption mechanisms by walking through the seven analytical steps of the Fraud Risk Assessment methodology as applicable to health programs. We then outline best practices for any anti-corruption mechanism, including a focus on quality health delivery; the alignment of actors' incentives around the advancement of health objectives; and being minimally corruptible by design.
BMJ Open
ObjectivesCorruption undermines the quality of healthcare and leads to inequitable access to essential health products. WHO, Global Fund, United Nations Development Programme (UNDP) and World Bank are engaged in anti-corruption in health sectors globally. Throughout the COVID-19 pandemic, weakened health systems and overlooked regulatory processes have increased corruption risks. The objective of this study is thus to explore the strengths and weaknesses of these organisations’ anti-corruption mechanisms and their trajectories since the pandemic began.Design, setting and participants25 semistructured key informant interviews with a total of 27 participants were conducted via Zoom between April and July 2021 with informants from WHO, World Bank, Global Fund and UNDP, other non-governmental organisations involved in anti-corruption and academic institutions. Key informant selection was guided by purposive and snowball sampling. Detailed interview notes were qualitatively coded by thre...
BMC Health Services Research
Background Policymaking in the pharmaceutical sector plays a pivotal role in achieving the health systems’ goals. Transparency in the pharmaceutical policy could increase confidence in decision-making processes. This study aims to assess transparency in the public pharmaceutical sector of Iran. Methods This qualitative study with a content analysis approach was conducted in 2017 using the World Health Organization tool to explore pharmaceutical transparency. The perceptions of the various stakeholders of the health system through semi-structured interviews with a maximum variation of stakeholders were obtained in eight functions, including registration, licensing, inspection, promotion, clinical trials, selection, procurement, and distribution of medicines. Results There are some problems in two main categories: (1) General problems, including lack of transparency, conflict of interest, centralization, and monopoly. (2) Ethical problems include illegal payments, gifts, bribes, confl...
Journal of Anti-Corruption Law
Uganda’s Covid-19 crisis response involved the mobilisation of resources from the international community and the private sector. The Ugandan parliament also appropriated a supplementary budget towards the response. To expedite the procurement of essential goods and supplies by government agencies, some public procurement procedures were not followed. As a result, tender prices were rigged, and the quality of products supplied was compromised. Fake vaccines were also sold to unsuspecting recipients. This article contends that acts of corruption did not only compromise health outcomes but also denied potential beneficiaries the right to health. This was despite existing anti-corruption laws and legal institutions. Some corruption-related suspects were arrested and prosecuted.
The GAVI Alliance – an alliance of the world's major players in global immunisation – uncovered massive misuse of its grants in Cameroon in 2011. GAVI's Transparency and Accountability Policy triggered an investigation into the financial management of Cameroon's Health Systems Strengthening grant. The investigation revealed that, of US$5.1 million programme expenditures, US$3.7 million had been misspent, partly due to fraud. Different types of corruption affected this programme. Analysing how misuse was detected and how GAVI and the government responded, provides lessons on how similar abuses can be prevented in the future. In order to avoid grant mismanagement, programmes should have integrated transparency and accountability systems. This is also applicable to programmes in other sectors. GAVI's support to Cameroon and its immunisation programme GAVI is a public-private partnership whose mission is to save children's lives and protect people's health by inc...
From the COVID-19 pandemic to corrupt practices: a tale of two evils
Environmental Science and Pollution Research
Emergencies and corruption go hand in hand in times of crisis. We are currently living in a pandemic phase, and corruption is even more damaging during these times of crisis that the world is experiencing with COVID-19. Vaccination is the only survival option that we have. The development of a nation will soon be measured by the criteria of who owns more vaccines. This study has four objectives. The first is to explore the most recent relevant literature. Moreover, we also investigate the unique trilogy of corruption, the environment, and the COVID-19 pandemic. The second is to identify adequate channels for distributing the COVID-19 vaccines. The vaccines should be dispersed based on the categories of age, gender, ethnicity, profession, and health conditions. Third, we explored the factors that are causing corruption in the distribution of the COVID-19 vaccines. Our findings show that unequal distribution, theft and black markets, weaponization of vaccines, logistical challenges, and substandard and falsified vaccines are the factors that potentially lead to corruption. The fourth objective is to investigate solutions for mitigating corruption. We revealed that blockchain, awareness, well-planned distribution channels, and prioritization of vulnerable groups are the steps that could effectively reduce corruption.